onapristone inntooltip international nonproprietary name developmental code names synthetic steroidal antiprogestogen additional antiglucocorticoid activity developed described never silent antagonist progesterone receptor pr contrast related antiprogestogen mifepristone weak partial agonist moreover compared mifepristone onapristone reduced antiglucocorticoid activity shows little antiandrogenic activity greater potency medication development clinical use instance treatment breast cancer endometrial contraceptive discontinued phase iii clinical trials due findings liver function abnormalities developed majority onapristone found effective treatment breast onapristone reemerged development treatment prostate cancer currently phase ii clinical also development treatment endometrial cancer breast cancer ovarian cancer uterine cancer discontinued indications favor focusing prostate httpsenwikipediaorgwikionapristone